Primarily, IL-6 activates signal transducer and activator of transcription 3 (STAT3) signaling thus promotes tumor cell proliferation and enhances cell invasiveness in cancers, which is in line with the constitutive activation of STAT3 in RCC, especially in metastatic disease13,14. The gene discussed is STAT3; the disease is renal cell adenocarcinoma.